Cargando…
A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression
BACKGROUND: Gastroesophageal reflux frequently occurs in infants from birth to 2 years and is characterised by reflux and regurgitation often occurring during or immediately after feeds. These reflux events can range in both frequency and severity, and as the reflux events increase, they become incr...
Autores principales: | Fisher, Jeanine, McLaughlin, Fiona, Fawkes, Neil, Tipple, Hannah, Coyle, Cathal, Dettmar, Peter W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8363677/ https://www.ncbi.nlm.nih.gov/pubmed/34283413 http://dx.doi.org/10.1007/s40268-021-00356-1 |
Ejemplares similares
-
Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy
por: Strugala, Vicki, et al.
Publicado: (2012) -
The Effect of Alginate in Gastroesophageal Reflux in Infants
por: Salvatore, Silvia, et al.
Publicado: (2018) -
Evaluation of an Innovative Over-the-Counter Treatment for Symptoms of Reflux Disease: Quick-Dissolving Alginate Granules
por: Strugala, Vicki, et al.
Publicado: (2012) -
Clinically Meaningful Difference for the Infant Gastroesophageal Questionnaire Revised version (I-GERQ-R): A Quantitative Synthesis
por: Smith, Adam B, et al.
Publicado: (2020) -
Reflux Revisited: Advancing the Role of Pepsin
por: Bardhan, Karna Dev, et al.
Publicado: (2012)